Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy.

Autor: Sato-Sano M; Department of Dermatology, Federal University of Sao Paulo, Sao Paulo, Brazil.; Oncology Center, Portuguese Beneficence of São Paulo, Sao Paulo, Brazil., Teixeira SP; Department of Dermatology, Federal University of Sao Paulo, Sao Paulo, Brazil., Vargas JC; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo, Sao Paulo, Brazil., Baiocchi OCCG; Department of Clinical and Experimental Oncology, Federal University of Sao Paulo, Sao Paulo, Brazil., Enokihara MMSES; Department of Dermatology, Federal University of Sao Paulo, Sao Paulo, Brazil.; Department of Pathology, Federal University of Sao Paulo, Sao Paulo, Brazil., Gomes EE; Oncology Center, Portuguese Beneficence of São Paulo, Sao Paulo, Brazil., Batista MD; Department of Dermatology, Federal University of Sao Paulo, Sao Paulo, Brazil.; Oncology Center, Portuguese Beneficence of São Paulo, Sao Paulo, Brazil.
Jazyk: angličtina
Zdroj: The Journal of dermatology [J Dermatol] 2019 Jul; Vol. 46 (7), pp. 618-621. Date of Electronic Publication: 2019 May 30.
DOI: 10.1111/1346-8138.14916
Abstrakt: Eosinophilic dermatosis of hematological malignancy is a paraneoplastic skin eruption associated with chronic lymphocytic leukemia and other B-cell malignancies. It clinically resembles an insect bite reaction and it can precede the symptoms of the hematological malignancy or be related to a more aggressive course. Different treatments have been proposed, but partial response and recurrence are frequent. Herein, we describe a case of eosinophilic dermatosis associated with mantle cell lymphoma with remission after lenalidomide therapy.
(© 2019 Japanese Dermatological Association.)
Databáze: MEDLINE
Externí odkaz: